Bladder Overactivity and Post-Botulinum Toxin Telemonitoring

Inclusion Criteria: * Patient with a neurogenic bladder or idiopathic overactive bladder. * Patient treated with intradetrusor botulinum toxin injection as part of their usual care, whether performing spontaneous voiding or self-catheterization. * Patient whose residence allows a home visit by a service provider within the area covered by the AGIR à dom group. * Patient affiliated with the social security system. * Patient willing to provide informed consent Exclusion Criteria: * Persons covered under Articles L1121-5 to L1121-8 of the French Public Health Code (CSP), corresponding to all protected persons: pregnant or postpartum women, breastfeeding mothers, individuals deprived of liberty by judicial or administrative decision, persons receiving psychiatric care under Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8, individuals admitted to a healthcare or social facility for purposes other than research, minors, persons under legal protection, or individuals unable to give consent. * Staff members with a hierarchical relationship with the principal investigator.